Abstract
This article reviews the magnitude and spectrum of ocular complications of HIV infection in sub-Sahara Africa. A literature search was done using PubMed, Google, and UpToDate and by talking to ophthalmologists and HIV experts working in the region. Ocular complications of HIV infection, mostly retinal, are seen in 29% to 71% of patients. Cytomegalovirus retinitis affects 0% to 16.5% of HIV-infected patients and is treated successfully with intravitreal ganciclovir in South Africa and Botswana. Ocular surface squamous neoplasia is seen in 4% to 7.8% of persons with HIV (a 5%–6% increase in Uganda and Tanzania), and recurrence after surgery occurs in 3.2% to 31.2%. In Zimbabwe, 45% of meningitis in adults is cryptococcal, and cryptococcal meningitis is the third leading cause of death in HIV patients in rural Uganda. In Rwanda, 9% of patients with cryptococcal meningitis developed visual loss and sixth nerve palsy. Thus, HIV infection leads to significant ocular morbidity in sub-Sahara Africa.
Similar content being viewed by others
References and Recommended Reading
Joint United Nations Programme on HIV/AIDS: AIDS Epidemic Update. Geneva: World Health Organization; 2007. Available at http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. Accessed February 15, 2008.
Cunningham ET Jr, Margolis TP: Ocular manifestations of HIV infection. N Engl J Med 1998, 339:236–244.
HIV/AIDS: what is the impact on prevention of blindness programmes. Community Eye Health 2003, 16:33–34.
Jaffar S, Ariyoshi K, Frith P, et al.: Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in The Gambia, West Africa. Trop Med Int Health 1999, 4:487–492.
Assefa Y, Yohannes A, Melese A: Ocular manifestations of HIV/AIDS patients in Gondar University Hospital, North West Ethiopia. Ethiop J Health Dev 2006, 20:166–169.
Ndoye NB, Sow PS, Ba EA, et al.: Ocular complications of AIDS in Dakar. Dakar Med 1993, 38:97–100.
Gichuhi S, Irlam JJ: Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. Cochrane Database Syst Rev 2007, 2:CD005643.
Poole TR: Conjunctival squamous cell carcinoma in Tanzania. Br J Ophthalmol 1999, 83:177–179.
Chisi SK, Kollmann MK, Karimurio J: Conjunctival squamous cell carcinoma in patients with human immunodeficiency infection seen at two hospitals in Kenya. East Afr Med J 2006, 83:267–270.
Semo B, Bison G, Nkomazana O: Immune status of HIV-positive patients with ocular surface squamous neoplasia in Botswana [abstract 27]. Presented at the 8th International Conference on Malignancies in HIV and Other Immunodeficiencies. Bethesda, MD; April 29–30, 2004.
Waddell KM, Lewallen S, Lucas SB, et al.: Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 1996, 80:503–508.
Ateenyi-Agaba C: Conjunctival squamous-cell carcinoma associated with HIV 1 infection in Kampala, Uganda. Lancet 1995, 345:695–696.
Guramatunhu S: Squamous cell carcinoma in HIV/AIDS. Community Eye Health 2003, 16:37.
Waddell KM, Downing RG, Lucas SB, Newton R: Corneo-conjunctival carcinoma in Uganda. Eye 2006, 20:893–899.
Mahomed A, Chetty R: Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Ach Ophthalmol 2002, 120:554–558.
Kiire CA, Dhillon B: The aetiology and associations of conjunctival intraepithelial neoplasia. Br J Ophthalmol 2006, 90:109–113.
Ateenyi-Agaba C, Dai M, Le Calvez F, et al.: TP53 mutations in squamous carcinomas of the conjunctiva: evidence for UV-induced mutagenesis. Mutagenesis 2004, 19:399–401.
Newton R, Ferlay J, Reeves G, et al.: Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 1996, 347:1450–1451.
Tornesello ML, Duraturo ML, Waddell KM, et al.: Evaluating the role of human papillomaviruses in conjunctival neoplasia. Br J Cancer 2006, 94:446–449.
Frucht-Pery J, Sugar J, Baum J, et al.: Mitomycin C treatment for conjunctival-cornela intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997, 104:2085–2093.
Sudesh S, Rapuano CJ, Cohen E, et al.: Surgical management of ocular surface squamous neoplasia: the experience from a cornea center. Cornea 2000, 19:278–283.
Jabs DA, Enger C, Bartlett JG: Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1997, 107:75–80.
Heiden D, Nathan W, Rodriguez WR, et al.: Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007, 4:e334.
Jacobson M: Clinical manifestations and diagnosis of AIDS related cytomegalovirus retinitis. UpToDate 2007, 16:1. Available at http://www.uptodate.com/patients/content/topic.do?topicKey=hiv_infe/6396. Accessed February 15, 2008.
Kestelyn P: The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm 1999, 7:3–4.
Jaffar S, Ariyoshi K, Frith P, et al.: Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in the Gambia, West Africa. Trop Med Int Health 1999, 4:487–492.
Cochereau I, Mlika-Cabanne N, Godinaud P, et al.: AIDS related eye disease in Burundi, Africa. Br J Ophthalmol 1999, 83:339–342.
Lewallen S, Kumwenda J, Maher D, et al.: Retinal findings in Malawian patients with AIDS. Br J Ophthalmol 1994, 78:757–759.
Beare NA, Kublin JG, Lewis DK, et al.: Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol 2002, 86:1076–1079.
Visser L: Managing CMV retinitis in the developing world. Community Eye Health 2003, 16:38–39.
Nkomazana O, Semo B: Outcome of CMV retinitis treatment in Botswana [poster]. Poster presented at the International AIDS Conference. Bangkok, Thailand; July 11–16, 2004.
Sugar AM: Overview of cryptococcosis in the patient with AIDS. Mycopathologia 1991, 114:153–157.
Heyderman RS, Gangaidzo IT, Hakim JG, et al.: Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998, 26:284–289.
Mayanja-Kizza H, Oishi K, Mitarai S, et al.: Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis 1998, 26:1362–1366.
Okongo M, Morgan D, Mayanja B, et al.: Causes of death in a rural population-based human immunodeficiency virus 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998, 27:698–702.
Kestelyn P, Taelman H, Bogaerts J, et al.: Ophthalmic manifestations of infections with cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1993, 116:721–727.
Bisson G, Nthobatsang R, Thakur R, et al.: The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in HIV-infected adults in Botswana [poster]. Poster presented at the 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3–6, 2008.
Mylonakis E, Merriman NA, Rich JD, et al.: Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. Diagn Microbiol Infect Dis 1999, 34:111–114.
Bach MC, Tally PW, Godofsky EW: Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997, 41:1280–1282.
Claus JJ, Portegies P: Reversible blindness in AIDS-related cryptococcal meningitis. Clin Neurol Neurosurg 1998, 100:51–52.
Sukla D, Rathinam SF, Cunningham ET, et al.: Contribution of HIV/AIDS to global blindness. Int Ophthalmol Clin 2007, 47:27–43.
World Health Organization: Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: World Health Organization; 2008.
Bouza E, Merino P, Munoz P, et al.: Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) 1997, 76:53–61.
Kestelyn PG, Cunningham ET Jr: HIV/AIDS and blindness. Bull World Health Organ 2001, 79:208–213.
Kestelyn PG, Lewallen S: Ocular problems with HIV infection and AIDS in Africa. Community Eye Health, 1995, 8:20–23.
Resnikoff S, Pascolini D, Etya’ale D, et al.: Global data on visual impairment in the year 2002. Bull World Health Organ 2004, 82:844–851.
Lewallen S, Courtright P: Blindness in Africa: present situation and future needs. Br J Ophthalmol 2001, 85:897–903.
Guex-Crosier Y, Telenti A: An epidemic of blindness: a consequence of improved HIV care? Bull World Health Organ 2001, 79:181.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nkomazana, O., Tshitswana, D. Ocular complications of HIV infection in sub-Sahara Africa. Curr HIV/AIDS Rep 5, 120–125 (2008). https://doi.org/10.1007/s11904-008-0019-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-008-0019-z